These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1714563)
41. Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L. Imai J; Lesiak K; Torrence PF J Biol Chem; 1985 Feb; 260(3):1390-3. PubMed ID: 2981855 [TBL] [Abstract][Full Text] [Related]
42. A route to 2',5'-oligoadenylates with increased stability towards phosphodiesterases. Itkes AV; Karpeisky MYa ; Kartasheva ON; Mikhailov SN; Moiseyev GP; Pfleiderer W; Charubala R; Yakovlev GI FEBS Lett; 1988 Aug; 236(2):325-8. PubMed ID: 2842187 [TBL] [Abstract][Full Text] [Related]
43. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists. Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011 [No Abstract] [Full Text] [Related]
45. Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate. Beigelman L; Matulic-Adamic J; Haeberli P; Usman N; Dong B; Silverman RH; Khamnei S; Torrence PF Nucleic Acids Res; 1995 Oct; 23(19):3989-94. PubMed ID: 7479047 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological activity of 5'-capped derivatives of 5'-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine. Imai J; Torrence PF Biochemistry; 1984 Feb; 23(4):766-74. PubMed ID: 6712921 [TBL] [Abstract][Full Text] [Related]
47. Chemical synthesis of 2',5'-oligoadenylate analogues. Charubala R; Pfleiderer W Prog Mol Subcell Biol; 1994; 14():114-38. PubMed ID: 7520327 [No Abstract] [Full Text] [Related]
48. Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine to the 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine dependent endoribonuclease: chain length, phosphorylation state, and heterocyclic base. Torrence PF; Imai J; Lesiak K; Jamoulle JC; Sawai H J Med Chem; 1984 Jun; 27(6):726-33. PubMed ID: 6737414 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases. Li G; Xiao W; Torrence PF J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179 [TBL] [Abstract][Full Text] [Related]
50. Photochemical crosslinking in oligonucleotide-protein complexes between a bromine-substituted 2-5A analog and 2-5A-dependent RNase by ultraviolet lamp or laser. Nolan-Sorden NL; Lesiak K; Bayard B; Torrence PF; Silverman RH Anal Biochem; 1990 Feb; 184(2):298-304. PubMed ID: 2327573 [TBL] [Abstract][Full Text] [Related]
51. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150 [TBL] [Abstract][Full Text] [Related]
52. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L. Nakanishi M; Goto Y; Kitade Y Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753 [TBL] [Abstract][Full Text] [Related]
53. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs. Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677 [TBL] [Abstract][Full Text] [Related]
54. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI). Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282 [No Abstract] [Full Text] [Related]
55. Synthesis and biological activity of a fluorescent analogue of 2-5A. Lesiak K; Torrence PF FEBS Lett; 1983 Jan; 151(2):291-6. PubMed ID: 6832358 [No Abstract] [Full Text] [Related]
56. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L. Cramer H; Geselowitz DA; Torrence PF Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231 [TBL] [Abstract][Full Text] [Related]
57. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides. Cramer H; Player MR; Torrence PF Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638 [TBL] [Abstract][Full Text] [Related]